Post-Operative Treatment With Ketorolac After Abdominal Myomectomy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

112 participants

Study Classification

INTERVENTIONAL

Study Start Date

1999-09-30

Study Completion Date

2001-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if ketorolac, given after abdominal myomectomy, will decrease the frequency of post-oerative fevers as well as improve post-operative pain management.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Robot-Assisted Laparoscopic Myomectomy Is an Improvement Over Laparotomy in Patients With a Limited Number of Fibroids

NCT00910468

Fibroid Uterus

COMPLETED

Analgesic Effect of Ketamine in Patients Undergoing Hysteroscopic Endometrial Thermal Ablation Surgery

NCT01106846

Pain

TERMINATED NA

Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal Myomectomy

NCT06325501

Myoma;Uterus

RECRUITING PHASE3

Improved Recovery Using Multimodal Peri-operative Analgesia in Minimally Invasive Myomectomy

NCT00978601

Anesthesia Myomectomy

COMPLETED NA

Study to Evaluate Analgesic Effect of IV Administration of Kappa Agonist CR845 For Hysterectomy Surgery

NCT01361568

Postoperative Pain

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Febrile Morbidity Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Placebo

Group Type PLACEBO_COMPARATOR

saline

Intervention Type DRUG

15mg IV every 6hrs for 4 doses

2

Ketorolac

Group Type ACTIVE_COMPARATOR

ketorolac

Intervention Type DRUG

15mg IV every6 hours for 4doses

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ketorolac

15mg IV every6 hours for 4doses

Intervention Type DRUG

saline

15mg IV every 6hrs for 4 doses

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Toradol

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ant patient undregoing abdominal myomectomy

Exclusion Criteria

* Patients with contraindication to NSAIDs including history of peptic ulcer disease, renal disease, bleeding diathesis, or hypersensitivity to NSAIDS

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes